Article: Endocardial Solutions Reports First Quarter Results, ISO 9002 Certification and CE Mark

MINNEAPOLIS/ST. PAUL, Minn., May 4 /PRNewswire/ -- Endocardial Solutions, Inc. (Nasdaq: ECSI), which is engaged in the development of diagnostic products for the electrophysiology market, today reported financial results for first quarter 1998 and receipt of ISO 9002 certification for its electrophysiology workstation and a CE mark for its Ensite(TM) Catheter.

For the first quarter ended March 31, 1998, Endocardial Solutions (ESI) reported a net loss of $6,217,383, or $.69 per share, compared with a net loss of $1,865,264, or $1.09 per share, for the same period in 1997. The 1998 loss includes expenses of $3,585,602 related to a license agreement with ...






Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!